Our scientific association is elated to invite you to the “International Conference and Expo on Biopharmaceutics”, which is slated during September 21-23, in Baltimore, USA.
OMICS Group International is a leading scientific event organizer, a pioneer and a union of open access publications, conferences, workshops, symposiums and exhibitions. OMICS Group International was established in the year 2007 and at present has pioneered the scientific world by publishing articles in about 400 Open Access Journals, conducting over 300 Scientific Meetings and numerous B2B Meetings. OMICS Group International is basking in the glory of success with the support of more than 1000 scientific associations, 30,000 editorial board members, and has gained 3.5 million followers in a span of 6 years to add to its credit. OMICS Group Conferences are scientific rostrums to unveil the novel developments and analyze the advantages and consequences by conglomerating au courant information in Science and Technology.
The annual Biopharmaceutical Summit aims at forming a platform to bring the researchers and experts in pharmaceutical and drug delivery industry from around the world under a common roof of knowledge. The present conference focuses on discussing the recent development strategies, advancements in the dissolution technologies, product development and challenges in the biopharmaceutical industry and more. Every now and then, researchers are coming up with new drug products and delivery systems to attain efficient drug delivery to the target sites; this conference provides an apt platform to critically analyze and understand these new approaches and issues.
Biopharma-2015 program will comprise of keynote sessions, workshops and symposiums. The major sessions include:Approaches to assess BABE studies, applied biopharmaceutics, biowaiver approaches, nanoparticle mediated pulmonary drug delivery and innovative drug delivery system. The conference will mirror the theme ‘Explore the Challenges in Biopharmaceutics and Drug Delivery Systems’.
Novel Approaches and Requirements to Assess BABE Studies
Applied Biopharmaceutics and Quality by Design for Dissolution/ReleaseRate
Drug Biopharmaceutic Data in Product Development
Biowaiver Approaches for New Drug Products
Current Issues in Bioequivalence of Oral Products
Nanoparticle-Mediated Pulmonary Drug Delivery
Interpenetrating Polymer Networks as Innovative Drug Delivery Systems
Evaluating the Controlled Release Properties of Inhaled Nanoparticles
Pharmaceutical Innovation in the 21st Century
Biopharmaceutic classification of drugs: New scientific approaches to international regulatory standards